Efficacy Study of Tamsulosin and Tolterodine Treatment for Chronic Prostatitis
Unknown statusNot applicableNCT00913315
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to determine whether tamsulosin and tolterodine are effective in the treatment of men with lower urinary tract symptoms and chronic prostatitis/chronic pelvic pain syndrome.
Study details
- Official title
- Efficacy Study of Tamsulosin and Tolterodine Treatment of Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Lower Urinary Tract Symptoms
- Conditions
- Interventions
- Drug: tolterodine
- Drug: tamsulosin
- Drug: placebo
- Sponsor
- Chongqing Medical University
- Collaborators
- Fuling Central Hospital of Chongqing City
- Start date
- 2009-08
- Primary completion
- 2009-10
- Sex
- Male
- Age range
- from 18 Years to 45 Years
- Results posted
- No results posted in this snapshot
- Countries
- China
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. diagnosis of CP/CPPS based on the classification of US National Institutes of Health, aged 18-45 years 2. total score of at least 12 on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) 3. urinary score of at least 4 on the CPSI 4. subjects who anticipate improving symptoms Exclusion Criteria: 1. previous treatment with any other alpha-adrenergic receptor blocker and antimuscarinic agents for symptoms of CP/CPPS or for any other reason 2. those who had had previous urinary tract infection with the last year 3. those who had been treat or were taking medication that could affect lower urinary tract function 4. those who met the criteria for chronic bacterial prostatitis after lower urinary tract localization studies 5. those who had other significant medical problems
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00913315